Neuphoria Therapeutics (STU:B1N0) Tax Rate % : -0.60% (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Neuphoria Therapeutics Tax Rate %?

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Neuphoria Therapeutics's Tax Expense for the three months ended in Dec. 2024 was €0.01 Mil. Neuphoria Therapeutics's Pre-Tax Income for the three months ended in Dec. 2024 was €-1.85 Mil. Therefore, Neuphoria Therapeutics's Tax Rate % for the quarter that ended in Dec. 2024 was -0.60%.

Neuphoria Therapeutics Tax Rate % Historical Data

The historical data trend for Neuphoria Therapeutics's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuphoria Therapeutics Tax Rate % Chart

Neuphoria Therapeutics Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Tax Rate %

Get a 7-Day Free Trial

3.45

2.11

0.88

0.64

0.56

Neuphoria Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24	Sep24	Dec24
Tax Rate %	Get a 7-Day Free Trial															0.64	0.76	-	14.10	-0.60

Neuphoria Therapeutics Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Neuphoria Therapeutics's Tax Rate % for the fiscal year that ended in Jun. 2024 is calculated as

Tax Rate %	=	Tax Expense (A: Jun. 2024 )	/	Pre-Tax Income (A: Jun. 2024 )
	=	-0.081	/	-14.473
	=	0.56 %

Neuphoria Therapeutics's Tax Rate % for the quarter that ended in Dec. 2024 is calculated as

Tax Rate %	=	Tax Expense (Q: Dec. 2024 )	/	Pre-Tax Income (Q: Dec. 2024 )
	=	0.011	/	-1.845
	=	-0.60 %

Neuphoria Therapeutics Tax Rate % Related Terms

Thank you for viewing the detailed overview of Neuphoria Therapeutics's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.

Neuphoria Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neuphoria Therapeutics Inc (STU:B1N0) » Definitions » Tax Rate %

Comparable Companies

Traded in Other Exchanges

NEUP:USA

Address

100 Summit Dr, Burlington, MA, USA, 01803

Website

https://www.bionomics.com.au

Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.

Neuphoria Therapeutics Headlines

No Headlines